Pancreatic immunoreactive somatostatin and diabetes mellitus

Atilla Ertan, Akira Arimura, Kemal Akdamar, Tetsuichi Shibata, Kate Groot, Mark Luciano, Frances J. Mather, Halil Degertekin, Naurang Agrawal, Jerome Ryan

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Pancreatic secretions were collected during endoscopic retrograde cholangiopancreatography from 15 subjects without pancreatic, biliary, or hepatic diseases, 11 patients with non-insulin-dependent diabetes, and 11 patients with insulin-dependent diabetes. Pancreatic secretion was stimulated by the intravenous administration of one unit of secretin per kilogram of body weight. Immunoreactive somatostatin (IRS) in the pancreatic juice of the nondiabetic subjects ranged from 43 to 97 pg/ml, in non-insulin-dependent diabetics from 5 to 3872, and in the insulin-dependent diabetics from 0 to 2093. IRS in insulin-dependent diabetics under good plasma glucose control ranged from 0 to 281 pg/ml, compared to those under poor control who ranged from 518 to 2093 pg/ml. These results indicate that IRS in pancreatic juice is higher in poorly controlled insulin-dependent diabetics than in well controlled insulin-dependent diabetics and nondiabetics. Whether these changes in IRS are purely secondary phenomena or play some pathogenetic role in the disturbed metabolism of diabetes remains to be proven. The chromatographic profile of IRS in pancreatic juice on both gel filtration and high-performance liquid chromatography has indicated that these IRS moieties represent somatostatin 14 and somatostatin 28.

Original languageEnglish (US)
Pages (from-to)625-630
Number of pages6
JournalDigestive Diseases and Sciences
Issue number7
StatePublished - Jul 1984

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology


Dive into the research topics of 'Pancreatic immunoreactive somatostatin and diabetes mellitus'. Together they form a unique fingerprint.

Cite this